Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/113189
Título: | Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet | Autores/as: | Razquin, Cristina Ruiz-Canela, Miguel Toledo, Estefania Hernández-Alonso, Pablo Clish, Clary B. Guasch-Ferré, Marta Li, Jun Wittenbecher, Clemens Dennis, Courtney Alonso-Gómez, Angel Fitó, Montse Liang, Liming Corella, Dolores Gómez-Gracia, Enrique Estruch, Ramon Fiol, Miquel Lapetra, Jose Serra Majem, Luis Ros, Emilio Aros, Fernando Salas-Salvadó, Jordi Hu, Frank B. Martínez-González, Miguel A. |
Clasificación UNESCO: | 32 Ciencias médicas 3206 Ciencias de la nutrición |
Palabras clave: | Atrial Fibrillation Case–Control Heart Failure Kynurenine Mediterranean Diet, et al. |
Fecha de publicación: | 2021 | Publicación seriada: | The American journal of clinical nutrition | Resumen: | BACKGROUND: The tryptophan-kynurenine pathway is linked to inflammation. We hypothesize that metabolites implicated in this pathway may be associated with the risk of heart failure (HF) or atrial fibrillation (AF) in a population at high risk of cardiovascular disease. OBJECTIVES: We aimed to prospectively analyze the associations of kynurenine-related metabolites with the risk of HF and AF and to analyze a potential effect modification by the randomized interventions of the PREDIMED (Prevención con Dieta Mediterránea) trial with Mediterranean diet (MedDiet). METHODS: Two case-control studies nested within the PREDIMED trial were designed. We selected 324 incident HF cases and 502 incident AF cases individually matched with ≤3 controls. Conditional logistic regression models were fitted. Interactions with the intervention were tested for each of the baseline plasma metabolites measured by LC-tandem MS. RESULTS: Higher baseline kynurenine:tryptophan ratio (OR for 1 SD: 1.20; 95% CI: 1.01, 1.43) and higher levels of kynurenic acid (OR: 1.19; 95% CI: 1.01, 1.40) were associated with HF. Quinolinic acid was associated with AF (OR: 1.15; 95% CI: 1.01, 1.32) and HF (OR: 1.25; 95% CI: 1.04, 1.49). The MedDiet intervention modified the positive associations of kynurenine (Pinteraction = 0.006), kynurenic acid (Pinteraction = 0.008), and quinolinic acid (Pinteraction = 0.033) with HF and the association between kynurenic acid and AF (Pinteraction = 0.02). CONCLUSIONS: We found that tryptophan-kynurenine pathway metabolites were prospectively associated with higher HF risk and to a lesser extent with AF risk. Moreover, an effect modification by MedDiet was observed for the association between plasma baseline kynurenine-related metabolites and the risk of HF, showing that the positive association of increased levels of these metabolites and HF was restricted to the control group. | URI: | http://hdl.handle.net/10553/113189 | DOI: | 10.1093/ajcn/nqab238 | Fuente: | The American journal of clinical nutrition[EISSN 1938-3207],v. 114 (5), p. 1646-1654, (Noviembre 2021) |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.